Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.

February 4, 2017

Chicago, Illinois
Sheraton Grand Chicago

Continuing Medical Education


Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex®, LLC designates this live educational activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) - US Physicians
Successful completion of this CME activity enables a participant to earn up to 4.25 MOC points towards the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is Imedex’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Points.

Who Should Attend

The proposed activities are designed to meet the educational needs of practicing community and academic oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc.) involved and/or interested in the therapeutic management of patients with breast cancer.


Upon completion of these educational activities, participants should be better able to:

  • Identify potential implications of recent basic science discoveries in shaping future clinical practice
  • Evaluate optimal strategies for breast cancer diagnosis and prognosis.
  • Interpret emerging data from clinical trials evaluating therapeutic approaches for early-stage and advanced breast cancer
  • Devise evidence-based diagnostic and treatment plans for patients with early-stage or advanced breast cancer
  • Evaluate new applications of primary and secondary breast cancer preventive strategies
  • Analyze long-term care practice recommendations for breast cancer survivors